Archives: Speakers

Tom Julian started his career in various dot coms and moved into digital health, working in managed care and then pharma. He was most recently at Bristol Myers Squibb where he led clinical trial innovation initiatives and built out the R&D group’s digital recruitment strategy. Tom is passionate about helping patients and puts them at the center of his work.

Dr. Solomon is a Clinician / Scientist with over 15 years of experience in clinical research and development in neuropsychiatry and neurodegenerative diseases. Previously to his role at Mind Med, Todd was a Director of Global Clinical Development at Avanir Pharmaceuticals leading development programs in neurologic and psychiatric disorders such as Schizophrenia and Traumatic Brain Injury. Prior to that, Todd served as the Associate Director of Clinical Programs and Data Science for CNS programs at Signant Health. He holds degrees in psychology and neuroscience (BA) from St. Lawrence University and Clinical Neuropsychology (PhD) from New York University. Todd completed his fellowship in neurodegenerative disease at Boston University School of Medicine where he served as an associate faculty member, clinician, and investigator for several years.

Steve Brandao has spent more than 30 years in research and development.  His experience includes time with a major pharmaceutical company, work with two leading SMO’s, and business development positions with large global CRO’s, a medical device CRO, and an EDC technology company.  He is currently the US Regional Director of Business Development for Novotech, an Asia-Pacific centered CRO with global capabilities.  Steve has a graduate degree in psychology and worked as a psychotherapist before starting his career in biopharma research and development.

Ms. Olorunnisola is currently VP – Innovation, Marketing & Digital in the Avantor Services business unit. She leads Innovation, Marketing and Digital Solutions for the Supply Chain (Lab) Services and Clinical Services. She has over 15 years of experience in the Medical Device and Life Science industry developing and executing digital and go-to-market strategies. Additionally, she has led the development and deployment of large-scale enterprise solutions. Ms. Olorunnisola received her BA in Electrical Engineering from the University of Illinois at Chicago.

Aubrey Verna guides eCOA product development using evolving industry needs and stakeholder-informed insights across sponsors, sites, and patients. Her experience includes building and executing product strategies starting with the creation of roadmaps all the way to product releases. Additionally, Aubrey has experience in the management of global eCOA programs and has oversight of the teams responsible for implementation.

Patrick has over 27 years’ experience in new drug development. He joined Regeneron in March 2020. His current role is the Head of the Global Clinical Trial Services group, responsible for global site management, central monitoring, study feasibility and site selection, study/site start up and eCOA and patient technology initiatives. Prior to this, Patrick spent 25 years at Pfizer, with most of his time spent in clinical program operations but also includes GCP Quality (level 1) and Analytics. Patrick has extensive international experience in drug development. He helped establish the Pfizer country office development teams in Latin America, India and other parts of Asia. Subsequently, Patrick spent 10 years in Pfizer’s Development Japan organization as Head of Japan Development Operations and Development Japan Portfolio & Project Management Groups. He was the recipient of the PGRD Achievement Award in 2007. Patrick is a former officer in the U.S. Army and is a veteran of the first Gulf War. He holds a bachelor’s degree in Biology from the University of Rhode Island and a Master of Business Administration from Temple University.